The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Non-alcoholic fatty liver disease and risk of new-onset heart failure: an updated meta-analysis of about 11 million individuals
Abstract
Objective Recent studies reported an association between non-alcoholic fatty liver disease (NAFLD) and increased risk of new-onset heart failure (HF). However, the magnitude of the risk and whether this risk changes with severity of liver disease remains uncertain. We performed a meta-analysis of observational studies to quantify the magnitude of the association between NAFLD and risk of new-onset HF. Design We systematically searched Scopus, Web of Science and PubMed from database inception to March 2022 to identify eligible observational studies, in which NAFLD was diagnosed by serum biomarkers/scores, International Classification of Diseases (ICD) codes, imaging techniques or liver histology. The primary outcome was new-onset HF, as assessed mainly by ICD codes. Data from selected studies were extracted, and meta-analysis was performed using random-effects models to obtain summary hazard ratios (HRs) with 95% CIs. Results We identified 11 longitudinal cohort studies with aggregate data on 11 242 231 middle-aged individuals from different countries and 97 716 cases of incident HF over a median of 10 years. NAFLD was associated with a moderately higher risk of new-onset HF (pooled random-effects hazard ratio 1.50, 95% CI 1.34 to 1.67, p<0.0001; I 2 =94.8%). This risk was independent of age, sex, ethnicity, adiposity measures, diabetes, hypertension and other common cardiovascular risk factors. Sensitivity analyses did not change these results. The funnel plot did not show any significant publication bias. Conclusion NAFLD is associated with a 1.5-fold higher long-term risk of new-onset HF, regardless of the presence of diabetes, hypertension and other common cardiovascular risk factors. However, the observational design of the studies does not allow for proving causality.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“heart failure (OR 1.5), 29”
From EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). (2024) · cites this paper as [29]
Citations
Cites
The PRISMA 2020 statement: An updated guideline for reporting systematic reviews
Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., et al. (2021) · BMJ · doi:10.1136/bmj.n71 · Cited by 108,283
Quantifying heterogeneity in a meta‐analysis
Higgins, J. P. T., & Thompson, S. G. (2002) · Statistics in Medicine · doi:10.1002/sim.1186 · Cited by 36,763
Meta-analysis of Observational Studies in Epidemiology<SUBTITLE>A Proposal for Reporting</SUBTITLE>
Stroup, D. F. (2000) · JAMA · doi:10.1001/jama.283.15.2008 · Cited by 20,623
2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab368 · Cited by 13,344
Cumpston, M., Li, T., Page, M. J., Chandler, J., Welch, V. A., Higgins, J. P., & Thomas, J. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.ed000142 · Cited by 7,218
Byrne, C. D., & Targher, G. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2014.12.012 · Cited by 3,162
Self-citationEstes, C., Razavi, H. A., Loomba, R. S., Younossi, Z. M., & Sanyal, A. J. (2017) · Hepatology · doi:10.1002/hep.29466 · Cited by 2,496
Nonalcoholic Fatty Liver Disease 2020: The State of the Disease
Cotter, T. G., & Rinella, M. E. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.01.052 · Cited by 1,251
Targher, G., Byrne, C. D., & Tilg, H. (2020) · Gut · doi:10.1136/gutjnl-2020-320622 · Cited by 879
Self-citation2019 Global NAFLD Prevalence: A Systematic Review and Meta-analysis
Le, M. H., Yeo, Y. H., Li, X., Li, J., Zou, B., Wu, Y., Ye, Q., Huang, D. Q., Zhao, C., Zhang, J., et al. (2022) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2021.12.002 · Cited by 711
Cited by
Sorted by citations
Tacke, F., Horn, P., Wai-Sun Wong, V., Ratziu, V., Bugianesi, E., Francque, S., Zelber-Sagi, S., Valenti, L., Roden, M., Schick, F., et al. (2024) · Journal of Hepatology · doi:10.1016/j.jhep.2024.04.031 · Cited by 2,210
MASLD: a systemic metabolic disorder with cardiovascular and malignant complications
Targher, G., Byrne, C. D., & Tilg, H. (2024) · Gut · doi:10.1136/gutjnl-2023-330595 · Cited by 1,082
Self-citation(2024) · Obesity Facts · doi:10.1159/000539371 · Cited by 545
Natural history and progression of metabolic dysfunction-associated steatotic liver disease
Hagström, H., Shang, Y., Hegmar, H., & Nasr, P. (2024) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(24)00193-6 · Cited by 310
The role of hepatokines in NAFLD
Stefan, N., Schick, F., Birkenfeld, A. L., Häring, H., & White, M. F. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2023.01.006 · Cited by 288
Metabolic Dysfunction–Associated Steatotic Liver Disease in Adults
Tilg, H., Petta, S., Stefan, N., & Targher, G. (2025) · JAMA · doi:10.1001/jama.2025.19615 · Cited by 309
Self-citationNon-alcoholic fatty liver disease: pathophysiological concepts and treatment options
Grander, C., Grabherr, F., & Tilg, H. (2023) · Cardiovascular Research · doi:10.1093/cvr/cvad095 · Cited by 236
Self-citationChew, N., Mehta, A., Goh, R. S. J., Zhang, A. A. Y., Chen, Y., Chong, B., Chew, H. S. J., Shabbir, A., Brown, A. C., Dimitriadis, G. K., et al. (2024) · Circulation · doi:10.1161/circulationaha.124.070535 · Cited by 191
Chan, K. E., Ong, E. Y. H., Chung, C. H., Ong, C. E. Y., Koh, B., Tan, D. J. H., Lim, W. H., Yong, J. N., Xiao, J., Wong, Z. Y., et al. (2023) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2023.09.018 · Cited by 155
Byrne, C. D., Armandi, A., Pellegrinelli, V., Vidal‐Puig, A., & Bugianesi, E. (2025) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-025-01045-z · Cited by 113
Self-citationMechanisms Linking Metabolic-Associated Fatty Liver Disease (MAFLD) to Cardiovascular Disease
Badmus, O. O., Hinds, T. D., & Stec, D. E. (2023) · Current Hypertension Reports · doi:10.1007/s11906-023-01242-8 · Cited by 90
Fan, J., Xu, X., Yang, R.-X., Nan, Y., Wei, L., Jia, J., Zhuang, H., Shi, J., Li, X., Cm, S., et al. (2024) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2024.00311 · Cited by 92
Chew, N., Pan, X. H., Chong, B., Chandramouli, C., Muthiah, M. D., & Lam, C. S. P. (2024) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2024.111652 · Cited by 63
Xiao, J., Ng, C. H., Chan, K. E., Fu, C., Tay, P., Yong, J. N., Lim, W. H., Tan, D. J. H., Syn, N., Wong, Z. Y., et al. (2023) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2022.11.006 · Cited by 56
Gries, J. J., Lazarus, J. V., Brennan, P., Siddiqui, M. S., Targher, G., Lang, C. C., Virani, S. S., Lavie, C. J., Isaacs, S. D., Arab, J. P., et al. (2024) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(24)00310-8 · Cited by 59
Self-citationMøller, S., Kimer, N., Hove, J. D., Barløse, M., & Gluud, L. L. (2025) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwae306 · Cited by 44
Hydes, T., Kennedy, O. J., Glyn‐Owen, K., Buchanan, R. M., Parkes, J., Cuthbertson, D. J., Roderick, P., & Byrne, C. D. (2024) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2024.03.045 · Cited by 35
Self-citationMASLD and MASH at the crossroads of hepatology trials and cardiorenal metabolic trials
Zannad, F. M., Sanyal, A. J., Butler, J., Ferreira, J. P., Girerd, N., Miller, V., Pandey, A., Parikh, C. R., Ratziu, V., Younossi, Z. M., et al. (2024) · Journal of Internal Medicine · doi:10.1111/joim.13793 · Cited by 38
Boeckmans, J., Prochaska, J. H., Gieswinkel, A., Böhm, M., Wild, P. S., & Schattenberg, J. M. (2024) · The Lancet Regional Health - Europe · doi:10.1016/j.lanepe.2024.101153 · Cited by 34
The global cardiovascular–liver–metabolic syndemic: epidemiology, trends and challenges
Chew, N., Mehta, A., Goh, R. J. L., Koh, J., Chen, Y., Chong, B., Chan, M. Y., Khan, M. S., Muthiah, M. D., Butler, J., et al. (2025) · Nature Reviews Cardiology · doi:10.1038/s41569-025-01220-4 · Cited by 35
Zhou, X., Chen, Q., Targher, G., Byrne, C. D., Shapiro, M. D., Tian, N., Xiao, T., Sung, K., Lip, G. Y. H., & Zheng, M. (2024) · Journal of the American Heart Association · doi:10.1161/jaha.123.032997 · Cited by 30
Self-citationCai, Y., Fang, L., Chen, F., Zhong, P., Zheng, X., Xing, H., Fan, R., Yuan, L., Peng, W., & Li, X. (2024) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2024.101052 · Cited by 31
Metabolic dysfunction-associated steatotic liver disease and the cardiovascular system
Manolis, A. A., Manolis, T. A., Vouliotis, A. I., & Manolis, A. S. (2025) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2025.01.001 · Cited by 33
Metabolic Dysfunction-Associated Steatotic Liver Disease: Pathogenetic Links to Cardiovascular Risk
Ionescu, V., Gheorghe, G., Bacalbaşa, N., & Diaconu, C. C. (2025) · Biomolecules · doi:10.3390/biom15020163 · Cited by 33
Mantovani, A., Morieri, M. L., Palmisano, L., Masulli, M., Cossu, E., Baroni, M. G., Bonomo, K., Cimini, F. A., Cavallo, M. G., Buzzetti, R., et al. (2023) · Cardiovascular Diabetology · doi:10.1186/s12933-023-01945-x · Cited by 29
Self-citationSanyal, A. J., Husain, M., Diab, C., Mangla, K. K., Shoeb, A., Lingvay, I., & Tapper, E. B. (2024) · American Heart Journal Plus Cardiology Research and Practice · doi:10.1016/j.ahjo.2024.100386 · Cited by 26
Fatty liver disease, heart rate and cardiac remodelling: Evidence from the UK Biobank
Jamialahmadi, O., Tavaglione, F., Rawshani, A., Ljungman, C. E. A., & Romeo, S. (2023) · Liver International · doi:10.1111/liv.15556 · Cited by 23
Roderburg, C., Krieg, S., Krieg, A. H., Vaghiri, S., Mohr, R. U., Konrad, M., Luedde, M., Luedde, T., Kostev, K., & Loosen, S. H. (2023) · Clinical Research in Cardiology · doi:10.1007/s00392-023-02250-z · Cited by 25
Epidemiology of NAFLD – Focus on diabetes
Younossi, Z. M., & Henry, L. L. (2024) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2024.111648 · Cited by 26
HFpEF and MASLD: converging mechanisms and clinical implications
Capone, F., Häseli, S. P., Liu, L., Strocchi, S., Langenberg, C., Lusis, A. J., Pietzner, M., Muoio, D. M., Rider, O. J., Raman, B., et al. (2026) · Nature Reviews Cardiology · doi:10.1038/s41569-026-01257-z · Cited by 35
Byrne, C. D., & Targher, G. (2024) · Metabolism and Target Organ Damage · doi:10.20517/mtod.2024.06 · Cited by 24
Self-citationGallo, G., Nalli, G., Baratta, F., Desideri, G., & Savoia, C. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26168081 · Cited by 27
Liver stiffness as a cornerstone in heart disease risk assessment
Boeckmans, J., Sandrin, L., Knackstedt, C., & Schattenberg, J. M. (2023) · Liver International · doi:10.1111/liv.15801 · Cited by 24
Non-Alcoholic Fatty Liver Disease as an Emerging Risk Factor for Heart Failure
Inciardi, R. M., Mantovani, A., & Targher, G. (2023) · Current Heart Failure Reports · doi:10.1007/s11897-023-00613-1 · Cited by 25
Self-citationMantovani, A., Lando, M. G., Borella, N. D., Scoccia, E., Pecoraro, B., Gobbi, F. G., Bisoffi, Z., Valenti, L. V. C., Tilg, H., Byrne, C. D., et al. (2024) · Liver International · doi:10.1111/liv.15925 · Cited by 25
Self-citationPecani, M., Andreozzi, P., Cangemi, R., Corica, B., Miglionico, M., Romiti, G. F., Stefanini, L., Raparelli, V., & Basili, S. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14082750 · Cited by 23
Branković, M., Dukić, M., Gmizić, T., Popadić, V., Nikolić, N., Sekulic, A. D., Brajković, M., Đokić, J., Mahmutović, E., Lasica, R., et al. (2024) · Diagnostics · doi:10.3390/diagnostics14020229 · Cited by 21
Wu, S., Li, Y., Zhang, Y., Su, X. Y., Zuo, Y., Chen, G., Xu, G., Chen, S., He, Y. L., & Wang, A. (2024) · Circulation Heart Failure · doi:10.1161/circheartfailure.123.010841 · Cited by 22
Aging at the Crossroads of Organ Interactions: Implications for the Heart
Sen, I., Trzaskalski, N. A., Hsiao, Y., Liu, P. P., Shimizu, I., & Dérumeaux, G. (2025) · Circulation Research · doi:10.1161/circresaha.125.325637 · Cited by 20
Li, Q., Wu, J., Sun, X., Huang, X., Huang, W., Weng, C., & Cai, J. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1119005 · Cited by 20
Liao, Y.-L., Zhu, G.-Y., & Chang, C. W. (2024) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1291438 · Cited by 20
Human Gut Microbiota in Cardiovascular Disease
Ronen, D., Rokach, Y., Abedat, S., Qadan, A., Daana, S., Amir, O., & Asleh, R. (2024) · Comprehensive physiology · doi:10.1002/cphy.c230012 · Cited by 28
Approach to the Patient With Nonalcoholic Fatty Liver Disease
Belfort‐DeAguiar, R., Lomonaco, R., & Cusi, K. J. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac624 · Cited by 16
Cardiometabolic Dysregulation and Heart Failure
Ashfield, S., & Ojha, U. (2025) · Reviews in Cardiovascular Medicine · doi:10.31083/rcm38504 · Cited by 14
Goodheart, R. H., & Ayonrinde, O. T. (2025) · Heart Lung and Circulation · doi:10.1016/j.hlc.2025.08.009 · Cited by 18
FILIPPO, O. D., Pietro, G. D., Nebiolo, M., Ribaldone, D. G., Gatti, M., Bruno, F., Gallone, G., Armandi, A., Birtolo, L. I., Zullino, V., et al. (2024) · European Journal of Clinical Investigation · doi:10.1111/eci.14188 · Cited by 14
Wongtrakul, W., Charatcharoenwitthaya, N., & Charatcharoenwitthaya, P. (2024) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000002719 · Cited by 14
Zhao, J., Yang, J., Yang, F., Wang, Y., Xia, Q., Ren, F., & Zhang, Y. (2025) · Food Chemistry · doi:10.1016/j.foodchem.2025.143134 · Cited by 13
Prognostic value of FIB-4 and NFS for cardiovascular events in patients with and without NAFLD
Zhang, J., Li, L., Lin, L., Wu, Y., Hu, L., Feng, Z., Zhang, D., Fu, T., Zhao, H., Yin, X., et al. (2025) · BMC Public Health · doi:10.1186/s12889-025-23883-x · Cited by 16
Metabolic dysfunction-associated fatty liver disease: bridging cardiology and hepatology
Zhou, X., Targher, G., Byrne, C. D., Shapiro, M. D., Chen, L.-L., & Zheng, M. (2024) · Cardiology Plus · doi:10.1097/cp9.0000000000000106 · Cited by 15
Self-citationPerspectives in weight control in diabetes – SGLT2 inhibitors and GLP-1–glucagon dual agonism
Iqbal, N., Ambery, P., Logue, J., Mallappa, A., & Sjöström, C. D. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110669 · Cited by 13
The importance of patient engagement in the multimodal treatment of MASLD
Boeckmans, J., Hagström, H., Cryer, D. R. H., & Schattenberg, J. M. (2025) · Communications Medicine · doi:10.1038/s43856-025-00871-1 · Cited by 16
Wegermann, K., Chouairi, F. K., Karachaliou, G. S., Ahlers, C. G., Au, S., Miller, K., Biering‐Sørensen, T., Abdelmalek, M. F., Diehl, A. M., Moylan, C. A., et al. (2025) · European Journal of Heart Failure · doi:10.1002/ejhf.3697 · Cited by 10
MAFLD: A Comprehensive Review of the Link Between Metabolic Dysfunction and Cardiovascular Risk
Mostafa, A. M., Pan, Z., Yu, M., Örmecı, N., Fouad, Y. M., & Eslam, M. (2025) · Hepatic Medicine Evidence and Research · doi:10.2147/hmer.s506402 · Cited by 15
Chuzi, S. E., Tanaka, Y., Bavishi, A. A., Bruce, M., VanWagner, L. B., Wilcox, J. E., Ahmad, F. S., Ladner, D. P., Lagu, T. C., & Khan, S. S. (2023) · Journal of General Internal Medicine · doi:10.1007/s11606-023-08199-z · Cited by 9
Braha, A., Timar, B., Ivan, V. M., Micloș-Balica, M., Dăniluc, L., & Timar, R. Z. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13195901 · Cited by 10
Attributable burden of steatotic liver disease on cardiovascular outcomes in Asia
Yin, S., Chen, Y.-T., Chang, W., Chen, T.-I., Yang, T.-H., Liu, X.-R., Huang, C.-W., Chen, Y., & Lee, M. (2025) · JHEP Reports · doi:10.1016/j.jhepr.2025.101479 · Cited by 10
Cho, Y. K., Kim, M. J., Kim, E. H., Lee, M. J., Nam, H.-J., Lee, W. J., Kim, H., & Jung, C. H. (2025) · Hepatology International · doi:10.1007/s12072-025-10924-1 · Cited by 9
Hoseini, Z., Behpour, N., & Hoseini, R. (2024) · Scientific Reports · doi:10.1038/s41598-024-57023-z · Cited by 9
Kim, D. W., Son, M., Lee, H. J., Choi, C. H., Kang, Y. W., Moon, S. Y., Koh, M., Lee, J. Y., Baek, Y. H., & An, W. S. (2025) · Hepatology Research · doi:10.1111/hepr.14226 · Cited by 9
Abdelhamed, W., Amin, M. A., Waked, I. A., & El‐Kassas, M. (2025) · World Journal of Gastroenterology · doi:10.3748/wjg.v31.i45.111643 · Cited by 5
Sudden cardiac death associated with fatty liver disease
Vo, J. C., Truyen, T. T. T. T., Uy‐Evanado, A., Sargsyan, A. S., Chugh, H. S., Young, C., Hurst, S., Miyake, C. Y., Reinier, K., & Chugh, S. S. (2025) · IJC Heart & Vasculature · doi:10.1016/j.ijcha.2025.101602 · Cited by 5
Huang, C.-H., Kor, C., & Chang, C. (2025) · Annals of Medicine · doi:10.1080/07853890.2025.2540020 · Cited by 5
Forst, T. M., Botz, I., Berse, M., Voswinkel, S., Strempler, M.-E., Baumann, S., & Marinez, M. (2023) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-023-01378-z · Cited by 4
Extrahepatic manifestation of metabolic dysfunction-associated steatotic liver disease
Shenoy, A., Ahmed, A., & Kim, D. (2025) · Metabolism and Target Organ Damage · doi:10.20517/mtod.2025.73 · Cited by 4
Ahmed, M. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14061841 · Cited by 5
Pantelis, A. G. (2023) · Metabolism and Target Organ Damage · doi:10.20517/mtod.2023.55 · Cited by 4
Boeckmans, J., Widman, L., Strandberg, R., Shang, Y., Wester, A., & Hagström, H. (2025) · BMJ Public Health · doi:10.1136/bmjph-2025-003322 · Cited by 3
Farmakis, D. T., Karampinos, K. I., Kapelios, C. J., Liori, S., Fountoulaki, K., & Filippatos, G. S. (2026) · European Heart Journal - Quality of Care and Clinical Outcomes · doi:10.1093/ehjqcco/qcag061 · Cited by 3
Zhao, M., Han, X., Fan, H. X., Liang, C., Wang, H., Zhang, X., Zhao, S., Guo, C., Liu, Z., & Zhang, T. (2024) · Liver International · doi:10.1111/liv.16136 · Cited by 3
Luong, T. V., Tran, H., Thi, B. N. C., Vu, H. M., Le, T., Le, T., Thi, H. N., Nguyen, H. M., Doan, T. C., Ho, A. B., et al. (2025) · World Journal of Cardiology · doi:10.4330/wjc.v17.i7.107751 · Cited by 5
Shavkuta, G. V., & Туркина, С. В. (2024) · South Russian Journal of Therapeutic Practice · doi:10.21886/2712-8156-2024-5-2-29-37 · Cited by 3
Chen, L.-Z., Jing, X., Chen, X., Xie, Y., Chen, Y., & Cai, X. (2024) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2509344 · Cited by 3
KAHL, S., Caussy, C., & Cusi, K. J. (2026) · Diabetologia · doi:10.1007/s00125-026-06817-z · Cited by 2
Cardiovascular disease in metabolic-associated fatty liver disease
Adams, L. A. (2023) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000803 · Cited by 2
Non-alcoholic fatty liver disease and cardiovascular risks: A review
Kotovskaya, Y. V. (2023) · Consilium Medicum · doi:10.26442/20751753.2023.4.202275 · Cited by 4
Bonapace, S., & Mantovani, A. (2024) · Metabolites · doi:10.3390/metabo14100528 · Cited by 3
Self-citationZhao, M., Liang, C., Huang, J., Dai, L., Wang, H., Zhang, X., Zhao, S., Guo, C., Liu, Z., & Zhang, T. (2025) · Clinical Nutrition · doi:10.1016/j.clnu.2025.04.006 · Cited by 2
Chen, F., Guo, Z., Chen, Y., Li, S., & Chen, P. (2025) · BMC Microbiology · doi:10.1186/s12866-025-04027-y · Cited by 2
Рашидовна, С. Р., Subkhangulova, D. O., & Khazova, E. V. (2024) · Kazan medical journal · doi:10.17816/kmj624813 · Cited by 1
Lee, J., & Shin, M. (2025) · Cardiovascular Prevention and Pharmacotherapy · doi:10.36011/cpp.2025.7.e2 · Cited by 1
Demidova, T. Y., Расуловна, Б. А., & Омариевна, У. Ф. (2025) · FOCUS Endocrinology · doi:10.62751/2713-0177-2025-6-2-09 · Cited by 1
Лазебник, Л. Б., Туркина, С. В., & Golovanova, E. V. (2024) · Экспериментальная и клиническая гастроэнтерология · doi:10.31146/1682-8658-ecg-230-10-11-35 · Cited by 1
Aleman, J., Vernetti, L. A., Schurdak, M. E., DeBiasio, R., LaRocca, G., Yechoor, V. K., Taylor, D. L., Stern, A. M., & Miedel, M. T. (2026) · BMC Biotechnology · doi:10.1186/s12896-026-01158-6 · Cited by 1
Lu, L., Gao, C., Wu, N., He, S., Liu, Y., Zhang, N., & Zhou, J. (2025) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2025-005135 · Cited by 1
Chen, H., Zheng, Y. F., Wu, H., Wang, N., & Tan, X. (2026) · Sleep research. · doi:10.1002/slp2.70025 · Cited by 1
Klisic, A. N., Tomašević, R., Đjurašković, S., Mercantepe, F., & Ninić, A. (2026) · Archives of Medical Science · doi:10.5114/aoms/219846 · Cited by 2
Butcko, A. J., Adeshina, K. A., Kamali, P., Teskey, G., Rahman, A. A., Jaster, J. V., Tiwari, N., Singh, N. K., Granneman, J. G., & Mottillo, E. P. (2026) · Scientific Reports · doi:10.1038/s41598-026-47839-2 · Cited by 2
吴学碧, Ma, Y., Yin, X., Liu, J., & Zhang, Y. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1863710 · Cited by 1
Yang, X., Cheng, K., Chen, C., Zhang, Y., & Wang, D. W. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27177734 · Cited by 1
Zhou, X., Jeong, S., Chen, Q., Targher, G., Byrne, C. D., Chew, N. W., Younossi, Z. M., Lip, G. Y. H., Tilg, H., George, J., et al. (2026) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-026-01255-z · Cited by 3
Self-citationDemidova, T. Y., Izmaylova, M. Y., & Скуридина, Д. В. (2023) · FOCUS Endocrinology · doi:10.15829/2713-0177-2023-3-17 · Cited by 1
Smid, V., & Dvořák, K. (2024) · Vnitřní lékařství · doi:10.36290/vnl.2024.013 · Cited by 2
Connecting Obesity and Reproductive Disorders
Ahima, R. S., & Dias, J. P. (2023) · Springer eBooks · doi:10.1007/978-3-031-40116-9_54 · Cited by 1
Boeckmans, J., & Schattenberg, J. M. (2023) · Liver International · doi:10.1111/liv.15567 · Cited by 1
Zhou, X., Chen, Q., Targher, G., Byrne, C. D., Shapiro, M. D., Tian, N., Xiao, T., Sung, K., Lip, G. Y. H., & Zheng, M. (2023) · medRxiv · doi:10.1101/2023.10.06.23296684 · Cited by 1
Self-citationButcko, A. J., Kamali, P., Tiwari, N., Rahman, A. A., Teskey, G., Adeshina, K. A., Singh, N. K., Granneman, J. G., & Mottillo, E. P. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.04.24.650494 · Cited by 1
MAFLD in Obesity with Deteriorating Glucose ControlPreprint
Forst, T. M., Botz, I., Berse, M., Voswinkel, S., Strempler, M.-E., Baumann, S., & Schultz, A. (2022) · Research Square · doi:10.21203/rs.3.rs-2393464/v1
Non-Alcoholic Fatty Liver in Obesity with Deteriorating Glucose ControlPreprint
Forst, T. M., Botz, I., Berse, M., Voswinkel, S., Strempler, M.-E., Baumann, S., & Schultz, A. (2023) · Research Square · doi:10.21203/rs.3.rs-2393464/v2
Livzan, M. A., Сергеевна, К. Т., & Syrovenko, M. I. S. (2023) · Экспериментальная и клиническая гастроэнтерология · doi:10.31146/1682-8658-ecg-212-4-133-139
Metadata
- Authors
- Mantovani, A., Petracca, G., Csermely, A., Beatrice, G., Bonapace, S., Rossi, A., Tilg, H., Byrne, C. D., & Targher, G.
- Affiliations
- University of Verona (IT)
- Ospedale Sacro Cuore Don Calabria (IT)
- Innsbruck Medical University (AT)
- University of Southampton (GB)
- Corresponding author
- Targher, Giovanni
- ORCID
- Venue
- Gut
- Publisher
- BMJ
- Published
- 2022-07-25
- Volume
- 72
- Issue
- 2
- Pages
- 372-380
- ISSN
- 0017-5749 (ISSN-L)
- 1468-3288
- OpenAlex
- W4287832822
- Cited by
- 128
- References
- 42
- Citations by year
- 2026: 28 · 2025: 34 · 2024: 37 · 2023: 26 · 2022: 3
- FWCI
- 3.97
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Gut (publishedVersion)
- PubMed (publishedVersion)
- ePrints Soton (University of Southampton) (acceptedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
- Keywords
- non-alcoholic fatty liver disease, heart failure, new-onset heart failure, cardiovascular risk, liver disease severity, diabetes mellitus, hypertension, cardiovascular risk factors, middle-aged adults
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
